Chauhan D - Search Results

1

A qualitative exploration of the patient experience of erosive and non-erosive hand osteoarthritis.

Panter C, Berry P, Chauhan D, Fernandes S, Gatsi S, Park J, Wells JR, Arbuckle R. Panter C, et al. Among authors: chauhan d. J Patient Rep Outcomes. 2021 Feb 3;5(1):18. doi: 10.1186/s41687-021-00286-1. J Patient Rep Outcomes. 2021. PMID: 33537932 Free PMC article.

2

Development, psychometric evaluation and cognitive debriefing of the rheumatoid arthritis symptom and impact questionnaire (RASIQ).

Becker B, Bracher M, Chauhan D, Rendas-Baum R, Lin X, Raymond K, O'Connor M, Kosinski M. Becker B, et al. Among authors: chauhan d. J Patient Rep Outcomes. 2021 Dec 11;5(1):129. doi: 10.1186/s41687-021-00400-3. J Patient Rep Outcomes. 2021. PMID: 34894330 Free PMC article.

3

Development of a Conceptual Model to Understand Disease Burden in Patients With Systemic Lupus Erythematosus and Organ Damage.

Broderick L, Chen WH, Levy RA, Mitchell Foster A, Umanzor Figueroa C, Gairy K, Chauhan D. Broderick L, et al. Among authors: chauhan d. J Health Econ Outcomes Res. 2023 Aug 18;10(2):30-38. doi: 10.36469/001c.82228. eCollection 2023. J Health Econ Outcomes Res. 2023. PMID: 37605768 Free PMC article.

4

Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve study.

Hunnicutt JN, Fairburn-Beech J, Georgiou ME, Richards A, Gregan YI, Quasny H, Chauhan D. Hunnicutt JN, et al. Among authors: chauhan d. Lupus Sci Med. 2022 Nov;9(1):e000710. doi: 10.1136/lupus-2022-000710. Lupus Sci Med. 2022. PMID: 36450407 Free PMC article.

5

Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study.

He X, Lloyd E, Cooper S, Li L, Chauhan D, Juliao P, Quasny H, Bao C. He X, et al. Among authors: chauhan d. Value Health Reg Issues. 2023 Sep;37:88-96. doi: 10.1016/j.vhri.2023.03.007. Epub 2023 Jun 26. Value Health Reg Issues. 2023. PMID: 37379801 Free article.

6

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.

Urowitz MB, Aranow C, Asukai Y, Bass DL, Bruce IN, Chauhan D, Dall'Era M, Furie R, Fox NL, Gilbride JA, Hammer A, Ginzler EM, Gonzalez-Rivera T, Levy RA, Merrill JT, Quasny H, Roth DA, Stohl W, van Vollenhoven R, Wallace DJ, Petri M. Urowitz MB, et al. Among authors: chauhan d. Arthritis Care Res (Hoboken). 2022 Nov;74(11):1822-1828. doi: 10.1002/acr.24901. Epub 2022 Aug 4. Arthritis Care Res (Hoboken). 2022. PMID: 35439360 Free PMC article. Review.

7

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks.

Neupane B, Shukla P, Slim M, Martin A, Petri M, Bertsias GK, Kim AHJ, Fanouriakis A, Levy RA, Chauhan D, Ballew N. Neupane B, et al. Among authors: chauhan d. Lupus Sci Med. 2023 May;10(1):e000907. doi: 10.1136/lupus-2023-000907. Lupus Sci Med. 2023. PMID: 37147022 Free PMC article.

8

Multiscale effects of the calcimimetic drug, etelcalcetide on bone health of rats with secondary hyperparathyroidism induced by chronic kidney disease.

Sharma S, Kumar S, Tomar MS, Chauhan D, Kulkarni C, Rajput S, Sadhukhan S, Porwal K, Guha R, Shrivastava A, Gayen JR, Kumar N, Chattopadhyay N. Sharma S, et al. Among authors: chauhan d. Bone. 2024 May 20;185:117126. doi: 10.1016/j.bone.2024.117126. Online ahead of print. Bone. 2024. PMID: 38777312

9

Increased incidence of co-trimoxazole induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.

Yiu D, Aguilar-Duran S, Edwards C, Chauhan D, Furness A, Turajlic S, Larkin J, Fearfield L, Heelan K. Yiu D, et al. Among authors: chauhan d. Br J Dermatol. 2024 May 16:ljae202. doi: 10.1093/bjd/ljae202. Online ahead of print. Br J Dermatol. 2024. PMID: 38753744 No abstract available.

10

Development and approval of novel injectables: enhancing therapeutic innovations.

Yadav P, Singh Y, Chauhan D, Yadav PK, Kedar AS, Tiwari AK, Shah AA, Gayen JR, Chourasia MK. Yadav P, et al. Among authors: chauhan d. Expert Opin Drug Deliv. 2024 Apr;21(4):639-662. doi: 10.1080/17425247.2024.2351987. Epub 2024 May 12. Expert Opin Drug Deliv. 2024. PMID: 38703363 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

901 results

Search Page